Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Formulation (4)
121 Articles Available
4
6
Can't find what you're looking for? Try our
advanced search
.
Drug Development
New Insulin Formulation Improves Mealtime Glycemic Control
PAO-M10-17-NI-011
Drug Development
Biotechs Collaborate to Develop Multifunctional Cancer Immunotherapies
PAO-M10-17-NI-009
DNA Binding Protein May Increase Ovarian Cancer Survival
PAO-M09-17-NI-034
FDA Approval
FDA Approves Grifols’ Prolastin-C Liquid
PAO-M09-17-NI-032
Abuse Deterrence
Fighting Prescription Drug Abuse with Demonstrated Abuse-Deterrent Formulations
PAP-Q3-17-CL-003
Innovation and Formulation
PTV-M03-17-IN-005
Topical Drug Formulations – Strong Growth Based on New Understandings: Q&A with BASF Pharma Solutions
PAO-M04-17-NI-014
Making it Simple
PTV-M11-16-AP-030
Focusing on Patient Compliance
PTV-M01-17-NS-011
Partnering for Formulation Development
PTV-M11-16-AP-001
Innovative Drug Delivery Technology
PTV-M11-16-AP-006
Choosing the Right Pathway
PTV-M11-16-AP-007
Servier Offers Quality Service
PTV-M11-16-AP-012
Enhancement and Availability
PTV-M11-16-AP-015
Freund Vector Can’t Go Wrong with Granurex
PTV-M11-16-AP-017
Expanding Capabilities
PTV-M11-16-AP-023
Understanding Solid State Properties for Formulation Success
PAO-M04-17-NI-001
Energizing Client Portfolios with Patient-Friendly Dosage Forms
PAP-Q1-17-CL-001
Spending on Excipients Grows & Diversifies
PAP-Q1-17-FA-004
Operational Excellence in Outsourced Fill-Finish Services
PAP-Q1-17-IC-001
Expanding the Commercial Options for Preparation of Amorphous Solid Dispersions
PAP-Q1-17-CL-006
Particle Engineering for Improved Bioavailability in Oral Solid Dose Medications
PAP-Q1-17-CL-014
Next-Generation OSD Manufacturing Strategy
PAP-Q1-17-CL-015
Enhancing Responsiveness with Embedded Flexibility
PAP-Q1-17-CL-008
«
4
6
»
.svg)